Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy
Comparison of Novel Articaine Lozenge Versus Placebo for Upper Gastrointestinal Endoscopy in Adults. A Randomized Double-blinded Controlled Study
Sponsor: Helsinki University Central Hospital
Listed as NCT02105090, this PHASE4 trial focuses on Abdominal Pain and Dyspepsia and remains ongoing. Sponsored by Helsinki University Central Hospital, it has been updated 10 times since 2014, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Jan 2026 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE4
▶ Show 5 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE4
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Unknown Status → Recruiting
-
Feb 2017 — Nov 2017 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status PHASE4
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Helsinki University Central Hospital
For direct contact, visit the study record on ClinicalTrials.gov .